Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) EBT Margin (2016 - 2025)

Historic EBT Margin for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to 14.58%.

  • Apyx Medical's EBT Margin rose 260300.0% to 14.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.77%, marking a year-over-year increase of 284800.0%. This contributed to the annual value of 48.45% for FY2024, which is 78000.0% down from last year.
  • As of Q3 2025, Apyx Medical's EBT Margin stood at 14.58%, which was up 260300.0% from 32.44% recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's EBT Margin ranged from a high of 7.02% in Q2 2023 and a low of 73.57% during Q1 2024
  • Over the past 5 years, Apyx Medical's median EBT Margin value was 43.72% (recorded in 2025), while the average stood at 42.05%.
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 1087600bps in 2021, then crashed by -467800bps in 2024.
  • Apyx Medical's EBT Margin (Quarter) stood at 11.15% in 2021, then tumbled by -321bps to 46.9% in 2022, then crashed by -39bps to 65.05% in 2023, then skyrocketed by 51bps to 32.13% in 2024, then skyrocketed by 55bps to 14.58% in 2025.
  • Its EBT Margin stands at 14.58% for Q3 2025, versus 32.44% for Q2 2025 and 43.72% for Q1 2025.